GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Accelerate Diagnostics Inc (STU:1A80) » Definitions » Shiller PE Ratio

Accelerate Diagnostics (STU:1A80) Shiller PE Ratio : (As of Jun. 06, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Accelerate Diagnostics Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Accelerate Diagnostics Shiller PE Ratio Historical Data

The historical data trend for Accelerate Diagnostics's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accelerate Diagnostics Shiller PE Ratio Chart

Accelerate Diagnostics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Accelerate Diagnostics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Accelerate Diagnostics's Shiller PE Ratio

For the Medical Devices subindustry, Accelerate Diagnostics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Accelerate Diagnostics's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Accelerate Diagnostics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Accelerate Diagnostics's Shiller PE Ratio falls into.



Accelerate Diagnostics Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Accelerate Diagnostics's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Accelerate Diagnostics's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.681/131.7762*131.7762
=-0.681

Current CPI (Mar. 2024) = 131.7762.

Accelerate Diagnostics Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -1.398 100.560 -1.832
201409 -1.552 100.428 -2.036
201412 -1.622 99.070 -2.157
201503 -1.848 99.621 -2.444
201506 -2.406 100.684 -3.149
201509 -2.227 100.392 -2.923
201512 -2.662 99.792 -3.515
201603 -2.604 100.470 -3.415
201606 -3.115 101.688 -4.037
201609 -3.029 101.861 -3.919
201612 -2.939 101.863 -3.802
201703 -2.524 102.862 -3.233
201706 -2.759 103.349 -3.518
201709 -2.601 104.136 -3.291
201712 -2.450 104.011 -3.104
201803 -3.001 105.290 -3.756
201806 -3.681 106.317 -4.562
201809 -3.514 106.507 -4.348
201812 -3.604 105.998 -4.480
201903 -3.540 107.251 -4.350
201906 -3.363 108.070 -4.101
201909 -3.360 108.329 -4.087
201912 -3.510 108.420 -4.266
202003 -3.529 108.902 -4.270
202006 -3.108 108.767 -3.765
202009 -2.802 109.815 -3.362
202012 -2.713 109.897 -3.253
202103 -3.444 111.754 -4.061
202106 -2.988 114.631 -3.435
202109 -1.275 115.734 -1.452
202112 -3.089 117.630 -3.460
202203 -1.816 121.301 -1.973
202206 -2.299 125.017 -2.423
202209 -1.848 125.227 -1.945
202212 -1.322 125.222 -1.391
202303 -1.597 127.348 -1.653
202306 -2.741 128.729 -2.806
202309 0.056 129.860 0.057
202312 -0.743 129.419 -0.757
202403 -0.681 131.776 -0.681

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Accelerate Diagnostics  (STU:1A80) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Accelerate Diagnostics Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Accelerate Diagnostics's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Accelerate Diagnostics (STU:1A80) Business Description

Traded in Other Exchanges
Address
3950 South Country Club Road, Suite 470, Tucson, AZ, USA, 85714
Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.

Accelerate Diagnostics (STU:1A80) Headlines

No Headlines